Optimisation of the anti-Trypanosoma brucei activity of the opioid agonist U50488 - Wikidata - wikimedia - TriplyDB

Optimisation of the anti-Trypanosoma brucei activity of the opioid agonist U50488

Optimisation of the anti-Trypanosoma brucei activity of the opioid agonist U50488

http://www.wikidata.org/entity/Q33990598

about

Whole-organism high-throughput screening against Trypanosoma brucei brucei.Discovery of Indoline-2-carboxamide Derivatives as a New Class of Brain-Penetrant Inhibitors of Trypanosoma brucei.Screening a protein kinase inhibitor library against Plasmodium falciparum.

P2860

Q34642037-69E79C74-74AE-4377-8109-75C2C4A8ABC4 Q35791902-E5BED567-9A45-4EED-89DF-6348A7D51B97 Q47162276-B785C2ED-2143-4303-905E-31B6C7F9D1F3

P2860

Optimisation of the anti-Trypanosoma brucei activity of the opioid agonist U50488

http://www.wikidata.org/entity/Q33990598

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Optimisation of the anti-Trypanosoma brucei activity of the opioid agonist U50488

@ast

Optimisation of the anti-Trypanosoma brucei activity of the opioid agonist U50488

@en

type

label

Optimisation of the anti-Trypanosoma brucei activity of the opioid agonist U50488

@ast

Optimisation of the anti-Trypanosoma brucei activity of the opioid agonist U50488

@en

prefLabel

Optimisation of the anti-Trypanosoma brucei activity of the opioid agonist U50488

@ast

Optimisation of the anti-Trypanosoma brucei activity of the opioid agonist U50488

@en

P1433

Q33990598-868F9167-1958-41FE-8FB3-3F28B9D22555

P1476

Q33990598-912AA953-F5DB-4B6A-8762-D659DEEF71FA

P2093

Q33990598-2B30560C-9A8F-4B0D-B01A-6E3227E1F8DD

Q33990598-458C7672-B634-42B4-AB88-80324D7EE5A2

Q33990598-4C9B97DC-AC99-4D19-B956-5312FAF59D70

Q33990598-4D0D65ED-40B9-4E48-BD5E-593FA854251A

Q33990598-5939D410-FE8B-49D8-9C79-67B21DC3B1E4

Q33990598-635BE083-7E74-442C-91DC-A6D89CBCF38C

Q33990598-690FD20D-1606-4BF4-995B-C8994A6B2055

Q33990598-8C2F2F59-36E0-4D14-96D7-AC292C616911

Q33990598-E44EB96F-45FA-40A1-B9BD-4A5168ED35E9

P2860

Q33990598-2D06C1F6-6245-4B80-8DFA-E184F194F95A

Q33990598-2E27FA46-C717-435C-8195-CA354C0A8273

Q33990598-3CB937EF-FF5E-4C61-9546-FED5664E2127

Q33990598-4EFFCE3B-0640-46CA-B85B-59E9540961E9

Q33990598-6233F801-8792-41B1-898E-A24D36EF211D

Q33990598-69461FD7-3C24-4138-9420-E29E7C239AD2

Q33990598-88557F6F-7125-4784-96ED-A5CE1C5B29DC

Q33990598-B0A85713-30F0-4081-84DB-6688C63F34B7

Q33990598-BC98C6A6-AF1E-43D5-9917-BA217B17D597

Q33990598-CC289D1B-B46D-4ECE-BAE7-C618142A1F3B

P304

Q33990598-E139B89B-D9B8-4C4F-A87A-19D660EEAB96

P31

Q33990598-D8DFFFE4-07A2-4C48-A569-BC5C66BA634A

P356

Q33990598-F1B8F909-9CC0-4443-A431-6F0ABA64352C

P433

Q33990598-583ECBD6-3620-44B5-870F-C6B6378B28ED

P478

Q33990598-238CFD9A-59F2-47DC-8106-738A6D27199F

P50

Q33990598-1B656392-7FB0-4323-B933-45B9E2D7B780

Q33990598-5EDF9804-C196-494E-A6BF-E5B63ED4E03C

Q33990598-64DECB6C-540F-4A60-A38D-014ABA86B1B3

Q33990598-91C0F9AA-177A-40FF-BC91-098B3D725F73

Q33990598-BE6ECF70-6F97-41D3-9D73-5110519F22DF

P577

Q33990598-6B48BC00-820E-469E-A0FF-BC4055A5D3DD

P5875

Q33990598-155E67A1-9591-403B-8F56-D572BF32DED6

P698

Q33990598-E0158B46-AE88-4B1D-A884-B38C88FB9CDC

P921

Q33990598-9909BDAB-0792-4123-87EE-D85F2C99A8F1

Q33990598-A2A3C127-4694-4F7B-9C64-88EAB43A7218

P932

Q33990598-7439F4C6-2272-4B26-AAF0-B42A79113F82

P356

P1433

P1476

Optimisation of the anti-Trypanosoma brucei activity of the opioid agonist U50488

@en

P2093

Daniel Spinks

http://www.w3.org/2001/XMLSchema#string

Iain T Collie

http://www.w3.org/2001/XMLSchema#string

Irene Hallyburton

http://www.w3.org/2001/XMLSchema#string

Julie A Frearson

http://www.w3.org/2001/XMLSchema#string

Kevin D Read

http://www.w3.org/2001/XMLSchema#string

Laura A T Cleghorn

http://www.w3.org/2001/XMLSchema#string

N Yi Mok

http://www.w3.org/2001/XMLSchema#string

Suzanne Norval

http://www.w3.org/2001/XMLSchema#string

Victoria C Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular Shape and Medicinal Chemistry: A Perspective

Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial

Identification of a κ-opioid agonist as a potent and selective lead for drug development against human African trypanosomiasis.

Benzeneacetamide amines: structurally novel non-m mu opioids.

Kinetoplastids: related protozoan pathogens, different diseases.

Drug discovery and development for neglected parasitic diseases.

Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.

The treatment of human African trypanosomiasis.

Alterations in the stereochemistry of the kappa-selective opioid agonist U50,488 result in high-affinity sigma ligands.

Highly selective kappa opioid analgesics. Synthesis and structure-activity relationships of novel N-[(2-aminocyclohexyl)aryl]acetamide and N-[(2-aminocyclohexyl)aryloxy]acetamide derivatives.

P304

1832-1840

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CMDC.201100278

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Alan H Fairlamb

Andrew Woodland

P577

2011-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51564249

http://www.w3.org/2001/XMLSchema#string

P698

21834094

http://www.w3.org/2001/XMLSchema#string

P921

Trypanosoma brucei

P932

3229842

http://www.w3.org/2001/XMLSchema#string